查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1288861

全球癌症支持性治疗药物市场研究报告 - 行业分析、规模、份额、增长、趋势和2023年至2030年预测

Global Cancer Supportive Care Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 99 Pages | 商品交期: 最快1-2个工作天内

价格

据推测，到2030年，全球癌症支持性治疗药物的需求将从2022年的19.21百万美元达到近27.32百万美元，2023-2030年期间的复合增长率为4.5%。

癌症护理支持性药物是那些通过保护特定器官或细胞来减少癌症治疗的伤害性副作用的药物。这些药物不用于癌症治疗。支持性药物有时也被称为保护性药物。癌症支持性治疗涉及的主要药物类别包括治疗贫血（CIA）的ESA，治疗中性粒细胞减少症（CIN）的G-CSF，治疗癌症引起的骨病的双磷酸盐，治疗恶心和呕吐（CINV）的止吐剂，以及治疗癌症疼痛的非甾体抗炎药。癌症支持性药物的副作用将主要取决于：药物类型、给药剂量和患者的整体健康状况。

市场动态：

全球范围内癌症发病率的增加以及与癌症治疗相关的许多副作用是在预测时间范围内推动癌症支持性护理药物市场的主要因素。除此之外，越来越多的生物仿制药的吸收和有效治疗方法的可用性是其他因素，为癌症支持性护理药物市场的增长添加燃料。另外，全球范围内医疗支出的增加和有益的医疗改革也对市场增长产生了积极影响。此外，靶向治疗药物的技术进步，比传统癌症治疗药物的副作用更小，预计在未来几年将引起更多需求。

报告包括波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清楚地了解行业结构，并在全球范围内评估竞争的吸引力。

此外，这些工具还对全球癌症支持性护理药物市场的每个应用/产品领域进行了全面评估。

区域分析：

这一部分涵盖了区域划分，强调了北美、欧洲、亚太、拉美、中东和非洲的癌症支持性护理药物市场的当前和未来需求。此外，报告还关注了所有主要地区的个别应用部分的需求。

该研究报告还涵盖了市场中主要参与者的全面概况和对全球竞争格局的深入看法。癌症支持性护理药物市场的主要参与者包括Amgen Inc、Merck & Co.公司、强生服务公司、Heron Therapeutics公司、诺华公司、葛兰素史克公司（GSK）、F. Hoffmann-La Roche有限公司、Helsinn Healthcare SA。这一部分包括对竞争格局的整体看法，其中包括各种战略发展，如主要的合并和收购、未来的能力、伙伴关系、财务概况、合作、新产品的开发、新产品的推出以及其他发展。

如果你有任何定制要求，请写信给我们。我们的研究团队可以根据您的需要提供定制报告。

目录

第1章：前言

  • 报告描述
    • 目的
    • 目标受众
    • 独特的销售主张（USP）和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法

第二章：执行摘要

  • 癌症支持性护理药物市场的亮点
  • 全球癌症支持性护理药物市场概况

第三章：癌症支持性治疗药物 - 行业分析

  • 简介
  • 癌症支持性护理药物市场的驱动因素
  • 癌症支持性护理药物市场的限制因素
  • 癌症支持性护理药物市场的机会
  • 癌症辅助治疗药物市场的趋势
  • 癌症辅助治疗药物市场的波特五力分析
  • 癌症辅助治疗药物的市场吸引力分析
    • 按治疗类别分類的市场吸引力分析
    • 市场吸引力分析：按地区划分

第四章：价值链分析

  • 癌症支持性护理药物价值链分析
  • 癌症支持性护理药物原材料分析
    • 原材料清单
    • 癌症辅助治疗药物原料厂家列表
    • 癌症辅助治疗药物主要原材料的价格趋势
  • 潜在买家名单
  • 营销渠道
    • 直接营销
    • 间接营销
    • 营销渠道的发展趋势

第五章：COVID-19爆发的影响分析

第六章：全球癌症支持性治疗药物市场分析：按治疗类别分类

  • 按治疗类别概述
  • 2015-2018年历史数据
  • 全球癌症支持性护理药物市场按治疗类别分析
  • G-CSFs（粒细胞集落刺激因子）的市场分析：按地区划分
  • ESAs（红细胞刺激剂）的市场分析：按地区划分
  • 抗化妆品的市场分析：按地区划分
  • 双磷酸盐的市场分析：按地区分类
  • 阿片类药物的市场分析：按地区分类
  • 非甾体抗炎药（NSAIDs）的市场分析：按地区划分

第七章 ：全球癌症支持性治疗药物市场分析：按地理区域划分

  • 区域展望
  • 简介
  • 北美洲
    • 概述和历史数据
    • 北美癌症支持性治疗药物市场估计：按市场划分
    • 北美癌症支持性治疗药物市场估计：按国家划分
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 概述和历史数据
    • 欧洲癌症辅助治疗药物市场估计：按市场细分划分
    • 欧洲癌症支持性治疗药物市场估计：按国家分类
    • 英国
    • 法国
    • 德国
    • 意大利
    • 俄罗斯
    • 欧洲其他地区
  • 亚太地区
    • 概述和历史数据
    • 亚太地区癌症辅助治疗药物市场估计：按市场分类
    • 亚太地区癌症辅助治疗药物市场估计：按国家划分
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚
    • 亚太其他地区
  • 拉美地区
    • 概述和历史数据
    • 拉丁美洲癌症支持性治疗药物市场估计：按市场划分
    • 拉丁美洲癌症辅助治疗药物市场估计：按国家划分
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 拉美其他地区
  • 中东和非洲
    • 概述和历史数据
    • 中东和非洲癌症辅助治疗药物市场估计：按市场分类
    • 中东和非洲癌症辅助治疗药物市场估计：按国家划分
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 南非
    • 中东和非洲其他地区

第八章：癌症支持性护理药物公司的竞争格局

  • 癌症支持性护理药物市场竞争
  • 伙伴关系/合作/协议
  • 合并和收购
  • 新产品发布
  • 其他方面的发展

第九章：公司简介

  • 公司份额分析
  • 市场集中度
  • Amgen Inc.
    • 公司概况
    • 产品
    • 近期发展情况
  • Merck & Co.
    • 公司概况
    • 产品
    • 近期发展
  • Johnson & Johnson Services, Inc.
    • 公司概况
    • 产品
    • 近期发展
  • Heron Theovartis
    • 公司概况
    • 产品
    • 近期发展
  • Novartis AG
    • 公司概况
    • 产品
    • 近期发展
  • GlaxoSmithKline plc (GSK)
    • 公司概况
    • 产品
    • 近期发展
  • F. Hoffmann-La Roche Ltd.
    • 公司概况
    • 产品
    • 近期发展
  • Helsinn Healthcare SA
    • 公司概况
    • 产品
    • 近期发展情况

注意 - 在公司简介中，财务细节和最近的发展情况要视情况而定，如果是私营公司，可能不包括在内。

Product Code: VMR11213519

The global demand for Cancer Supportive Care Drugs Market is presumed to reach the valuation of nearly USD 27.32 MN by 2030 from USD 19.21 MN in 2022 with a CAGR of 4.5% during the period of 2023-2030.

Cancer care supportive drugs are those drugs that are used to reduce the injurious side effects of cancer treatment by protecting specific organs or cells. These drugs are not used for cancer treatment. Supportive drugs are sometimes also called as protective drugs. The major drug classes involved in cancer supportive care include ESAs for the treatment of Anemia (CIA), G-CSFs for neutropenia (CIN), bisphosphonates for cancer-induced bone diseases, antiemetics for nausea and vomiting (CINV), and NSAIDs for treating cancer pain. The side effects of cancer supportive drugs will depend primarily on: drug type, the dose given, and the overall health of the patients.

Market Dynamics:

The increasing prevalence of cancer globally and many side effects associated with cancer treatment are the major factors driving the cancer supportive care drug market over the forecast time frame. In addition to that, increasing uptake of biosimilars and the availability of effective treatment methods are other factors that add fuel to the growth of the cancer supportive care drugs market. Also, rising expenditure on healthcare and beneficial healthcare reforms worldwide are positively impacting market growth. Moreover, the technological advancements in targeted therapy drugs, which have lesser side effects than traditional cancer therapy drugs, is anticipated to give rise to more demand in the coming years.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of cancer supportive care drugs.

Market Segmentation:

The entire cancer supportive care drugs market has been sub-categorized into therapeutic class. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Therapeutic Class

  • G-CSFs (Granulocyte-colony Stimulating Factors)
  • ESAs (Erythropoiesis Stimulating Agents)
  • Anti-Emetics
  • Bisphosphonates
  • Opioids
  • (Non Steroidal Anti-Inflammatory Drugs) NSAIDs

Regional Analysis:

This section covers regional segmentation which accentuates on current and future demand for cancer supportive care drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cancer supportive care drugs market include Amgen Inc, Merck & Co. Inc., Johnson & Johnson Services Inc., Heron Therapeutics Inc., Novartis AG, GlaxoSmithKline plc (GSK), F. Hoffmann-La Roche Ltd., Helsinn Healthcare SA. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Cancer Supportive Care Drugs Market
  • 2.2. Global Cancer Supportive Care Drugs Market Snapshot

3 . CANCER SUPPORTIVE CARE DRUGS - INDUSTRY ANALYSIS

  • 3.1. Introduction
  • 3.2. Market Drivers of Cancer Supportive Care Drugs Market
  • 3.3. Market Restraints of Cancer Supportive Care Drugs Market
  • 3.4. Opportunities of Cancer Supportive Care Drugs Market
  • 3.5. Trends of Cancer Supportive Care Drugs Market
  • 3.6. Porter's Five Force Analysis of Cancer Supportive Care Drugs Market
  • 3.7. Cancer Supportive Care Drugs Market Attractiveness Analysis
    • 3.7.1 Market Attractive Analysis by Therapeutic Class
    • 3.7.2 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Cancer Supportive Care Drugs Value Chain Analysis
  • 4.2. Cancer Supportive Care Drugs Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Cancer Supportive Care Drugs Raw Material Manufactures List
    • 4.2.3. Price Trend of Cancer Supportive Care Drugs Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL CANCER SUPPORTIVE CARE DRUGS MARKET ANALYSIS BY THERAPEUTIC CLASS

  • 6.1 Overview by Therapeutic Class
  • 6.2 Historical Data 2015-2018
  • 6.3 Global Cancer Supportive Care Drugs Market Analysis by Therapeutic Class
  • 6.4 Market Analysis of G-CSFs (Granulocyte-colony Stimulating Factors) by Regions
  • 6.6 Market Analysis of ESAs (Erythropoiesis Stimulating Agents) by Regions
  • 6.5 Market Analysis of Anti-Emetics by Regions
  • 6.7 Market Analysis of Bisphosphonates by Regions
  • 6.8 Market Analysis of Opioids by Regions
  • 6.9 Market Analysis of (Non Steroidal Anti-Inflammatory Drugs) NSAIDs by Regions

7 . GLOBAL CANCER SUPPORTIVE CARE DRUGS MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America
    • 7.3.1. Overview and Historic Data
    • 7.3.2. North America Cancer Supportive Care Drugs Market Estimate By Market Segment
    • 7.3.3. North America Cancer Supportive Care Drugs Market Estimate By Country
    • 7.3.4. United State
    • 7.3.5. Canada
    • 7.3.6. Mexico
  • 7.4. Europe
    • 7.4.1. Overview and Historic Data
    • 7.4.2. Europe Cancer Supportive Care Drugs Market Estimate by Market Segment
    • 7.4.3. Europe Cancer Supportive Care Drugs Market Estimate by Country
    • 7.4.4. United Kingdom
    • 7.4.5. France
    • 7.4.6. Germany
    • 7.4.7. Italy
    • 7.4.8. Russia
    • 7.4.9. Rest Of Europe
  • 7.5. Asia Pacific
    • 7.5.1. Overview and Historic Data
    • 7.5.2. Asia Pacific Cancer Supportive Care Drugs Market Estimate by Market Segment
    • 7.5.3. Asia Pacific Cancer Supportive Care Drugs Market Estimate by Country
    • 7.5.4. China
    • 7.5.5. India
    • 7.5.6. Japan
    • 7.5.7. South Korea
    • 7.5.8. Australia
    • 7.5.9. Rest Of Asia Pacific
  • 7.6. Latin America
    • 7.6.1. Overview and Historic Data
    • 7.6.2. Latin America Cancer Supportive Care Drugs Market Estimate by Market Segment
    • 7.6.3. Latin America Cancer Supportive Care Drugs Market Estimate by Country
    • 7.6.4. Brazil
    • 7.6.5. Argentina
    • 7.6.6. Peru
    • 7.6.7. Chile
    • 7.6.8. Rest of Latin America
  • 7.7. Middle East & Africa
    • 7.7.1. Overview and Historic Data
    • 7.7.2. Middle East & Africa Cancer Supportive Care Drugs Market Estimate by Market Segment
    • 7.7.3. Middle East & Africa Cancer Supportive Care Drugs Market Estimate by Country
    • 7.7.4. Saudi Arabia
    • 7.7.5. UAE
    • 7.7.6. Israel
    • 7.7.7. South Africa
    • 7.7.8. Rest Of Middle East And Africa

8 . COMPETITIVE LANDSCAPE OF THE CANCER SUPPORTIVE CARE DRUGS COMPANIES

  • 8.1. Cancer Supportive Care Drugs Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF CANCER SUPPORTIVE CARE DRUGS INDUSTRY

  • 9.1. Company Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Amgen Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Financials
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Merck & Co.
    • 9.4.1. Company Overview
    • 9.4.2. Financials
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Johnson & Johnson Services, Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Financials
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Heron Theovartis
    • 9.6.1. Company Overview
    • 9.6.2. Financials
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Novartis AG
    • 9.7.1. Company Overview
    • 9.7.2. Financials
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. GlaxoSmithKline plc (GSK)
    • 9.8.1. Company Overview
    • 9.8.2. Financials
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. F. Hoffmann-La Roche Ltd.
    • 9.9.1. Company Overview
    • 9.9.2. Financials
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Helsinn Healthcare SA
    • 9.10.1. Company Overview
    • 9.10.2. Financials
    • 9.10.3. Products
    • 9.10.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Global Cancer Supportive Care Drugs Market Snapshot
  • Drivers of The Global Cancer Supportive Care Drugs Market Impact Analysis
  • Restraints of The Global Cancer Supportive Care Drugs Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Global Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Historic Data 2015-2018
  • Global Cancer Supportive Care Drugs Market Analysis in G-CSFs (Granulocyte-colony Stimulating Factors) by Geography ( USD MN)
  • Global Cancer Supportive Care Drugs Market Analysis in ESAs (Erythropoiesis Stimulating Agents) by Geography ( USD MN)
  • Global Cancer Supportive Care Drugs Market Analysis in Anti-Emetics by Geography ( USD MN)
  • Global Cancer Supportive Care Drugs Market Analysis in Bisphosphonates by Geography ( USD MN)
  • Global Cancer Supportive Care Drugs Market Analysis in Opioids by Geography ( USD MN)
  • Global Cancer Supportive Care Drugs Market Analysis in (Non Steroidal Anti-Inflammatory Drugs) NSAIDs by Geography ( USD MN)
  • Global Cancer Supportive Care Drugs Market by Geography ( USD MN)
  • Historic Data 2015-2018
  • North America Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • North America Cancer Supportive Care Drugs Market Estimate by Country ( USD MN)
  • United State Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Canada Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Mexico Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Europe Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Europe Cancer Supportive Care Drugs Market Estimate by Country ( USD MN)
  • United Kingdom Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • France Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Germany Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Italy Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Russia Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Spain Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Rest of Europe Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Asia Pacific Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Asia Pacific Cancer Supportive Care Drugs Market Estimate by Country ( USD MN)
  • China Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Japan Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • India Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • South Korea Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Australia Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Rest of Asia Pacific Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Latin America Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Latin America Cancer Supportive Care Drugs Market Estimate by Country ( USD MN)
  • Brazil Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Argentina Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Peru Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Chile Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Rest of Latin America Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Middle East & Africa Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Middle East & Africa Cancer Supportive Care Drugs Market Estimate by Country ( USD MN)
  • Saudi Arabia Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • UAE Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Israel Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • South Africa Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Rest of Middle East and Africa Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Cancer Supportive Care Drugs Report
  • Market Research Process
  • Market Research Methodology
  • Global Cancer Supportive Care Drugs Market Size, by Region (2019)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Therapeutic Class
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Cancer Supportive Care Drugs Market Analysis by Therapeutic Class
  • Global Cancer Supportive Care Drugs Market Analysis in G-CSFs (Granulocyte-colony Stimulating Factors) by Region
  • Global Cancer Supportive Care Drugs Market Analysis in ESAs (Erythropoiesis Stimulating Agents) by Region
  • Global Cancer Supportive Care Drugs Market Analysis in Anti-Emetics by Region
  • Global Cancer Supportive Care Drugs Market Analysis in Bisphosphonates by Region
  • Global Cancer Supportive Care Drugs Market Analysis in Opioids by Region
  • Global Cancer Supportive Care Drugs Market Analysis in (Non Steroidal Anti-Inflammatory Drugs) NSAIDs by Region
  • Global Cancer Supportive Care Drugs Market by Revenue
  • North America Cancer Supportive Care Drugs Market by Revenue
  • Europe Cancer Supportive Care Drugs Market by Revenue
  • Asia Pacific Cancer Supportive Care Drugs Market by Revenue
  • Latin America Cancer Supportive Care Drugs Market by Revenue
  • Middle East & Africa Cancer Supportive Care Drugs Market by Revenue
  • Recent Development in Cancer Supportive Care Drugs Industry
  • Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.